Riskpilot← Back to searchSign inGet full accessSPECIALLÆGE NIELS VEIEN ApS
APSActiveCVR 16980536Glamsbjergvej 18Medical specialists activities · NACE 8622Est. 19931 employees
Revenue 2024
DKK -59K
+122% vs 2023
EBITDA margin
268.7%
-498% vs 2023
Equity ratio
97.8%
Financial strength
Net profit 2024
DKK 1,1M
-4% vs 2023
| Revenue | DKK -59K | +122% |
| EBITDA | DKK -159K | -498% |
| Net profit | DKK 1,1M | -4% |
| Total assets | DKK 13,9M | +11% |
| Equity | DKK 13,6M | +9% |
| Employees | 1 | — |
Legal name
SPECIALLÆGE NIELS VEIEN ApS
CVR number
16980536
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
13. maj 1993
Share capital
DKK 200.000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af samtlige bestyrelsesmedlemmer i forening eller af en direktør alene, dog skal mindst een ansvarlig speciallæge være med i tegningen.
Company purpose
Selskabets formål er at drive speciallægevirksomhed og virksomhed, der er naturligt forbundet hermed.
Address
Glamsbjergvej 18
Phone
+4598165973
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -17 | -19 | -24 | -27 | -59 |
| Staff expenses | -50 | -56 | -50 | -0 | -100 |
| EBITDA | -67 | -76 | -74 | -27 | -159 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 |
| EBIT | -67 | -76 | -74 | -27 | -159 |
| Net financials | 722 | 1.375 | -1.637 | 1.590 | 1.581 |
| Profit before tax | 655 | 1.300 | -1.711 | 1.563 | 1.421 |
| Tax | 144 | 287 | -376 | 377 | 282 |
| Net profit | 511 | 1.013 | -1.335 | 1.186 | 1.140 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 11.749 | 12.720 | 11.321 | 12.503 | 13.920 |
| Equity | 11.603 | 12.616 | 11.281 | 12.467 | 13.607 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 145 | 104 | 40 | 36 | 313 |
| Total debt | 145 | 104 | 40 | 36 | 313 |
EBITDA margin
-15926800.0%
This company
15.8%
Market median
-100802632% vs market
20202024
Equity ratio
97.8%
This company
38.2%
Market median
+156% vs market
20202024
Return on equity
8.4%
This company
18.4%
Market median
-54% vs market
20202024
Net profit margin
113951900.0%
This company
8.1%
Market median
+1406813480% vs market
20202024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 1993 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 1993 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SPECIALLÆGE NIELS VEIEN ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karen Kay Veien | Board of Directors | 0 companies |